Connection

WILLIAM DECKER to Cancer Vaccines

This is a "connection" page, showing publications WILLIAM DECKER has written about Cancer Vaccines.
Connection Strength

1.500
  1. Dendritic cell vaccination plus low-dose doxorubicin for the treatment of spontaneous canine hemangiosarcoma. Cancer Gene Ther. 2019 09; 26(9-10):282-291.
    View in: PubMed
    Score: 0.557
  2. Cytokine adjuvants for vaccine therapy of neoplastic and infectious disease. Cytokine Growth Factor Rev. 2011 Aug; 22(4):177-87.
    View in: PubMed
    Score: 0.333
  3. Dendritic cell immunotherapy for the treatment of neoplastic disease. Biol Blood Marrow Transplant. 2006 Feb; 12(2):113-25.
    View in: PubMed
    Score: 0.227
  4. A retrogen plasmid-based vaccine generates high titer antibody responses against the autologous cancer antigen survivin and demonstrates anti-tumor efficacy. Cancer Lett. 2006 Jun 08; 237(1):45-55.
    View in: PubMed
    Score: 0.218
  5. Neoantigen vaccination induces clinical and immunologic responses in non-small cell lung cancer patients harboring EGFR mutations. J Immunother Cancer. 2021 07; 9(7).
    View in: PubMed
    Score: 0.165
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.